Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation

Background  The interpretation of the true effect of GH replacement therapy (GHRT) on metabolic status in GH deficiency (GHD) is often complicated by differing aetiologies of GHD and by the presence of additional hormone deficits.

[1]  C. Cowell,et al.  Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. , 2005, Bone.

[2]  N. Mauras,et al.  Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  M. Salerno,et al.  Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement , 2004, Clinical endocrinology.

[4]  W. Blum,et al.  Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  D. Dunger,et al.  Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. , 2004, The Journal of clinical endocrinology and metabolism.

[6]  W. Hop,et al.  Long-Term Effects of Growth Hormone Therapy on Bone Mineral Density, Body Composition, and Serum Lipid Levels in Growth Hormone Deficient Children: A 6-Year Follow-Up Study , 2002, Hormone Research in Paediatrics.

[7]  P. Clayton,et al.  Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan , 2002, Clinical endocrinology.

[8]  W. Blum,et al.  Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. , 2002, The Journal of clinical endocrinology and metabolism.

[9]  T. Hara,et al.  Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low‐density lipoprotein cholesterol levels during GH treatment in GH‐deficient children , 2002, Clinical endocrinology.

[10]  J. A. Barreto-Filho,et al.  Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. , 2002, The Journal of clinical endocrinology and metabolism.

[11]  M. Thorner,et al.  Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. , 2002, American journal of physiology. Endocrinology and metabolism.

[12]  J. Wells,et al.  The potential of near infra-red interactance for predicting body composition in children , 2001, European Journal of Clinical Nutrition.

[13]  J. Wit,et al.  Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  A. Rogol,et al.  Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. , 2001, Metabolism: clinical and experimental.

[15]  C. Cowell,et al.  Safety issues in children and adolescents during growth hormone therapy--a review. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[16]  A. Hokken-Koelega,et al.  Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. , 2000, The Journal of clinical endocrinology and metabolism.

[17]  N. Skakkebaek,et al.  Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. , 2000, The Journal of clinical endocrinology and metabolism.

[18]  N. Skakkebaek,et al.  Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. , 2000, The Journal of clinical endocrinology and metabolism.

[19]  M. Ranke,et al.  Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment , 2000, The Lancet.

[20]  B. Bengtsson,et al.  Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects* , 1999 .

[21]  P. Clayton,et al.  Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone‐releasing hormone (GHRH) receptor , 1999, Clinical endocrinology.

[22]  S. Norgren,et al.  Growth Hormone Treatment Downregulates Serum Leptin Levels in Children Independent of Changes in Body Mass Index , 1999, Hormone Research in Paediatrics.

[23]  M. Levine,et al.  Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. , 1999, The Journal of clinical endocrinology and metabolism.

[24]  R. Kuromaru,et al.  Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. , 1998, The Journal of clinical endocrinology and metabolism.

[25]  B. Silverman,et al.  Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  S. Loche,et al.  Effect of long‐term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency , 1998, Clinical endocrinology.

[27]  E. Krenning,et al.  Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. , 1997, The Journal of clinical endocrinology and metabolism.

[28]  R. Kuromaru,et al.  Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment , 1996, Acta paediatrica.

[29]  W. Castelli.  Lipids, risk factors and ischaemic heart disease. , 1996, Atherosclerosis.

[30]  P. Saenger,et al.  Carbohydrate metabolism in children receiving growth hormone for 5 years , 1996, Pediatric Nephrology.

[31]  T J Cole,et al.  Cross sectional stature and weight reference curves for the UK, 1990. , 1995, Archives of disease in childhood.

[32]  H. Kohno,et al.  Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. , 1995, The Journal of pediatrics.

[33]  H. de Boer,et al.  Clinical aspects of growth hormone deficiency in adults. , 1995, Endocrine reviews.

[34]  G. B. Schaefer,et al.  Lipids and apolipoproteins in growth hormone-deficient children during treatment. , 1994, Metabolism: clinical and experimental.

[35]  M. Hassan,et al.  Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. , 1994, The Journal of clinical endocrinology and metabolism.

[36]  R. Eston,et al.  Body Fat Estimations by Electrical Impedance and Infra-Red Interactance , 1992, International journal of sports medicine.

[37]  N. Vaisman,et al.  Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. , 1992, Metabolism: clinical and experimental.

[38]  J. Guevara-Aguirre,et al.  Growth Hormone Receptor Deficiency (Laron Syndrome): Clinical and Genetic Characteristics , 1991, Acta paediatrica Scandinavica. Supplement.

[39]  L. Romics,et al.  Effect of Growth Hormone on Serum Lipoproteins in Growth Hormone Deficiency , 1987, Experimental and clinical endocrinology.

[40]  D. Matthews,et al.  The role of human growth hormone in the regulation of cholesterol and bile acid metabolism. , 1983, The Journal of clinical endocrinology and metabolism.

[41]  P. Blackett,et al.  Growth hormone in the regulation of hyperlipidemia. , 1982, Metabolism: clinical and experimental.

[42]  R. Winter,et al.  Serum cholesterol and triglycerides in children with growth hormone deficiency. , 1979, Metabolism: clinical and experimental.

[43]  H. Ranney,et al.  Hemoglobin components in patients with diabetes mellitus. , 1971, The New England journal of medicine.

[44]  J. A. Barreto-Filho,et al.  Lack of Evidence of Premature Atherosclerosis in Untreated Severe Isolated Growth Hormone Deficiency Due to a GHRH Receptor Mutation , 2006 .